I've been sitting on these Janoshik results for a few weeks and wanted to pair them with my usage experience before posting. Here goes: What I tested: QSC Tirzepatide 30mg vials, Batch #TZ-2025-1189, ordered November 2025 from US warehouse. Janoshik Results: - Identity: ✅ Confirmed Tirzepatide - Purity (HPLC): 98.7% - Related substances: 1.3% total impurities (within expected range) - Endotoxin: Not tested (peptide panel only) - Cost of testing: $120 USD My 16-week research log (started at 2.5mg, currently at 10mg): - Weeks 1-4: 2.5mg/week — mild nausea first 2 doses, appetite suppression noticeable by week 2 - Weeks 5-8: 5mg/week — significant appetite reduction, lost 14 lbs, mild constipation managed with fiber - Weeks 9-12: 7.5mg/week — continued loss, 22 lbs total, energy levels great - Weeks 13-16: 10mg/week — 31 lbs down total, minimal side effects at this point Blood glucose went from 108 fasting to 87. A1C dropped from 5.9 to 5.2 per my last labs. These results are consistent with pharmaceutical tirzepatide studies. Bottom line: QSC tirzepatide at 98.7% purity is performing exactly as expected based on clinical literature. I'm a believer. 📊